The global HPV Testing And Pap Test market size is expected to be worth around US$ 10.3 billion by 2030, according to a new report by Vision Research Reports.
The global HPV Testing And Pap Test market size was valued at US$ 2.7 billion in 2020 and is anticipated to grow at a CAGR of 18.4% during forecast period 2021 to 2030.
Growth Factors
The introduction of innovative tests, increasing awareness programs, rising public-private investments, and high incidence of HPV infections are some of the factors anticipated to foster market growth during the forecast period.
Cervical cancer is a global problem, affecting millions of women. As per the Globocan estimates, in 2020, around 604,127 new cases of the cervix and uterine cancer were diagnosed globally, which led to around 341,831 deaths in the same year. According to the WHO, 99% of cervical cancer cases are linked with HPV infection. Such a high incidence and mortality rate of the disease has created a major demand for innovative and accurate screening for early detection and management. In addition, approval of novel testing solutions and services to upsurge screening rates is further anticipated to support market growth. In April 2020, Roche received FDA approval for its cobas HPV screening to be used on cobas 6800/8800 Systems, a fully automated and high-throughput system. Also, in February 2019, the Japanese company CMIC Healthcare Co., Ltd. launched SelCheck Cervical Cancer, a self-collect HPV test service focused on increasing the frequency of screening rates in the country.
Report Highlights
The Pap test segment dominated the market for HPV testing and Pap test in 2020 with a revenue share of 65.0%, owing to its widespread implementation in screening programs. Furthermore, increasing initiatives to increase awareness about Pap tests is further expected to fuel the segment growth.
The HPV testing segment is anticipated to witness a CAGR of 20.6% over the forecast period, owing to the commercialization of innovative tests and increasing government recommendations to use more efficient HPV screenings.
The cervical cancer screening segment dominated the market for HPV testing and Pap test and held the largest revenue share at 78.7% in 2020. The segment is expected to witness a CAGR of 20.9% during the forecast period. This dominance and fast growth are anticipated to the higher incidence of cervical cancer as compared to vaginal cancer.
the vaginal cancer screening segment is expected to witness a CAGR of 18.4% during the forecast period. Increasing prevalence and high mortality rates of vaginal cancer have propelled the demand for effective screening tests.
The consumables segment dominated the market for HPV testing and Pap test and accounted for the largest revenue share of 70.7% in 2020, owing to its repetitive usage in HPV and cervical screenings. Also, continuous development activities by key players operating in the market and the introduction of innovative consumables, such as assays & kits, for more accurate diagnosis of HPV and Pap are anticipated to boost segment growth.
The services segment is expected to witness the fastest CAGR during the forecast period, owing to the introduction of self and at-home HPV screening services to increase the frequency of cervical cancer screening rates in key markets.
The other technologies segment dominated the market for HPV testing and Pap test and accounted for the largest revenue share of 50.9% in 2020. This large share can be attributed to the high adoption of colposcopy and cystoscopy techniques in HPV and cervical cancer screenings. The other technologies segment includes colposcopy and cystoscopy.
the PCR segment is expected to witness the fastest growth in the technology segment, owing to the implementation of new guidelines to utilize DNA HPV testing methods due to its better accuracy and cost-effectiveness.
The hospitals and clinics segment dominated the market for HPV testing and Pap test and accounted for the largest revenue share of 54.5% in 2020, as they serve as primary care settings for diagnosis and treatment of all diseases, including HPV infections and cervical cancer.
The other segment is expected to show the fastest growth in the end-use segment, owing to the increasing use of the POC tests in-home care settings. Recent advancements in the POC test kits have resulted in shorter turnaround times and error-free results, which is expected to boost the market for HPV testing and Pap test over the forecast years. However, the lack of availability of highly accurate POC testing kits is expected to be a significant factor hampering its market growth during the study period.
North America dominated the HPV testing and Pap test market and held the largest revenue share of 45.1% in 2020 and is projected to maintain the lead throughout the forecast period. High awareness about early diagnosis of cervical cancer, well-established screening guidelines, and favorable healthcare reimbursement scenario are the factors driving the growth of the market in the region. In addition, high affordability, adoption, and access to technologically advanced products and services have further boosted the growth of the market in the region. Furthermore, the local presence of leading players and ongoing strategic initiatives undertaken by them has significantly supported the growth of the market in the region.
Key Players
Abbott Laboratories
Qiagen N.V.
Becton, Dickinson and Company
Quest Diagnostics, Inc.
Hologic, Inc.
F. Hoffmann-La Roche
Femasys, Inc.
Arbor Vita Corporation
NURX, Inc.
Seegene, Inc.
Thermo Fisher Scientific, Inc.
bioMérieux SA
Market Segmentation
Test Type Outlook
HPV Testing
Pap Test
Application Outlook
Cervical Cancer Screening
Vaginal Cancer Screening
Product Outlook
Instruments
Consumables
Services
Technology Outlook
PCR
Immunodiagnostics
Other Technologies
End-use Outlook
Hospitals & Clinics
Laboratories
Other End Users
Regional Outlook
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Russia
Asia Pacific
Japan
China
India
South Korea
Australia
Singapore
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
Saudi Arabia
UAE
The HPV Testing And Pap Test market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of HPV Testing And Pap Test market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global HPV Testing And Pap Test market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the HPV Testing And Pap Test market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted HPV Testing And Pap Test market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the HPV Testing And Pap Test capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of HPV Testing And Pap Test by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global HPV Testing And Pap Test market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major HPV Testing And Pap Test market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of HPV Testing And Pap Test market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the HPV Testing And Pap Test industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
HPV Testing And Pap Test market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to HPV Testing And Pap Test market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of HPV Testing And Pap Test market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new HPV Testing And Pap Test market. These factors have benefited the growth of the global market for HPV Testing And Pap Test. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for HPV Testing And Pap Test. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of HPV Testing And Pap Test are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global HPV Testing And Pap Test Market, By Test Type
7.1. HPV Testing And Pap Test Market, by Test Type, 2020-2030
7.1.1. HPV Testing
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Pap Test
7.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global HPV Testing And Pap Test Market, By Product
8.1. HPV Testing And Pap Test Market, by Product, 2020-2030
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Consumables
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global HPV Testing And Pap Test Market, By Application
9.1. HPV Testing And Pap Test Market, by Application, 2020-2030
9.1.1. Cervical Cancer Screening
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Vaginal Cancer Screening
9.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global HPV Testing And Pap Test Market, By Technology
10.1. HPV Testing And Pap Test Market, by Technology, 2020-2030
10.1.1. PCR
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Immunodiagnostics
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Other Technologies
10.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global HPV Testing And Pap Test Market, By End-use
11.1. HPV Testing And Pap Test Market, by End-use, 2020-2030
11.1.1. Hospitals & Clinics
11.1.1.1. Market Revenue and Forecast (2016-2030)
11.1.2. Laboratories
11.1.2.1. Market Revenue and Forecast (2016-2030)
11.1.3. End-use
11.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 12. Global HPV Testing And Pap Test Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.1.2. Market Revenue and Forecast, by Product (2016-2030)
12.1.3. Market Revenue and Forecast, by Application (2016-2030)
12.1.4. Market Revenue and Forecast, by Technology (2016-2030)
12.1.5. Market Revenue and Forecast, by End-use (2016-2030)
12.1.6. U.S.
12.1.6.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.1.6.2. Market Revenue and Forecast, by Product (2016-2030)
12.1.6.3. Market Revenue and Forecast, by Application (2016-2030)
12.1.6.4. Market Revenue and Forecast, by Technology (2016-2030)
12.1.6.5. Market Revenue and Forecast, by End-use (2016-2030)
12.1.7. Rest of North America
12.1.7.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.1.7.2. Market Revenue and Forecast, by Product (2016-2030)
12.1.7.3. Market Revenue and Forecast, by Application (2016-2030)
12.1.7.4. Market Revenue and Forecast, by Technology (2016-2030)
12.1.7.5. Market Revenue and Forecast, by End-use (2016-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.2.2. Market Revenue and Forecast, by Product (2016-2030)
12.2.3. Market Revenue and Forecast, by Application (2016-2030)
12.2.4. Market Revenue and Forecast, by Technology (2016-2030)
12.2.5. Market Revenue and Forecast, by End-use (2016-2030)
12.2.6. UK
12.2.6.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.2.6.2. Market Revenue and Forecast, by Product (2016-2030)
12.2.6.3. Market Revenue and Forecast, by Application (2016-2030)
12.2.6.4. Market Revenue and Forecast, by Technology (2016-2030)
12.2.6.5. Market Revenue and Forecast, by End-use (2016-2030)
12.2.7. Germany
12.2.7.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.2.7.2. Market Revenue and Forecast, by Product (2016-2030)
12.2.7.3. Market Revenue and Forecast, by Application (2016-2030)
12.2.7.4. Market Revenue and Forecast, by Technology (2016-2030)
12.2.7.5. Market Revenue and Forecast, by End-use (2016-2030)
12.2.8. France
12.2.8.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.2.8.2. Market Revenue and Forecast, by Product (2016-2030)
12.2.8.3. Market Revenue and Forecast, by Application (2016-2030)
12.2.8.4. Market Revenue and Forecast, by Technology (2016-2030)
12.2.8.5. Market Revenue and Forecast, by End-use (2016-2030)
12.2.9. Rest of Europe
12.2.9.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.2.9.2. Market Revenue and Forecast, by Product (2016-2030)
12.2.9.3. Market Revenue and Forecast, by Application (2016-2030)
12.2.9.4. Market Revenue and Forecast, by Technology (2016-2030)
12.2.9.5. Market Revenue and Forecast, by End-use (2016-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.3.2. Market Revenue and Forecast, by Product (2016-2030)
12.3.3. Market Revenue and Forecast, by Application (2016-2030)
12.3.4. Market Revenue and Forecast, by Technology (2016-2030)
12.3.5. Market Revenue and Forecast, by End-use (2016-2030)
12.3.6. India
12.3.6.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.3.6.2. Market Revenue and Forecast, by Product (2016-2030)
12.3.6.3. Market Revenue and Forecast, by Application (2016-2030)
12.3.6.4. Market Revenue and Forecast, by Technology (2016-2030)
12.3.6.5. Market Revenue and Forecast, by End-use (2016-2030)
12.3.7. China
12.3.7.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.3.7.2. Market Revenue and Forecast, by Product (2016-2030)
12.3.7.3. Market Revenue and Forecast, by Application (2016-2030)
12.3.7.4. Market Revenue and Forecast, by Technology (2016-2030)
12.3.7.5. Market Revenue and Forecast, by End-use (2016-2030)
12.3.8. Japan
12.3.8.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.3.8.2. Market Revenue and Forecast, by Product (2016-2030)
12.3.8.3. Market Revenue and Forecast, by Application (2016-2030)
12.3.8.4. Market Revenue and Forecast, by Technology (2016-2030)
12.3.8.5. Market Revenue and Forecast, by End-use (2016-2030)
12.3.9. Rest of APAC
12.3.9.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.3.9.2. Market Revenue and Forecast, by Product (2016-2030)
12.3.9.3. Market Revenue and Forecast, by Application (2016-2030)
12.3.9.4. Market Revenue and Forecast, by Technology (2016-2030)
12.3.9.5. Market Revenue and Forecast, by End-use (2016-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.4.2. Market Revenue and Forecast, by Product (2016-2030)
12.4.3. Market Revenue and Forecast, by Application (2016-2030)
12.4.4. Market Revenue and Forecast, by Technology (2016-2030)
12.4.5. Market Revenue and Forecast, by End-use (2016-2030)
12.4.6. GCC
12.4.6.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.4.6.2. Market Revenue and Forecast, by Product (2016-2030)
12.4.6.3. Market Revenue and Forecast, by Application (2016-2030)
12.4.6.4. Market Revenue and Forecast, by Technology (2016-2030)
12.4.6.5. Market Revenue and Forecast, by End-use (2016-2030)
12.4.7. North Africa
12.4.7.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.4.7.2. Market Revenue and Forecast, by Product (2016-2030)
12.4.7.3. Market Revenue and Forecast, by Application (2016-2030)
12.4.7.4. Market Revenue and Forecast, by Technology (2016-2030)
12.4.7.5. Market Revenue and Forecast, by End-use (2016-2030)
12.4.8. South Africa
12.4.8.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.4.8.2. Market Revenue and Forecast, by Product (2016-2030)
12.4.8.3. Market Revenue and Forecast, by Application (2016-2030)
12.4.8.4. Market Revenue and Forecast, by Technology (2016-2030)
12.4.8.5. Market Revenue and Forecast, by End-use (2016-2030)
12.4.9. Rest of MEA
12.4.9.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.4.9.2. Market Revenue and Forecast, by Product (2016-2030)
12.4.9.3. Market Revenue and Forecast, by Application (2016-2030)
12.4.9.4. Market Revenue and Forecast, by Technology (2016-2030)
12.4.9.5. Market Revenue and Forecast, by End-use (2016-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.5.2. Market Revenue and Forecast, by Product (2016-2030)
12.5.3. Market Revenue and Forecast, by Application (2016-2030)
12.5.4. Market Revenue and Forecast, by Technology (2016-2030)
12.5.5. Market Revenue and Forecast, by End-use (2016-2030)
12.5.6. Brazil
12.5.6.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.5.6.2. Market Revenue and Forecast, by Product (2016-2030)
12.5.6.3. Market Revenue and Forecast, by Application (2016-2030)
12.5.6.4. Market Revenue and Forecast, by Technology (2016-2030)
12.5.6.5. Market Revenue and Forecast, by End-use (2016-2030)
12.5.7. Rest of LATAM
12.5.7.1. Market Revenue and Forecast, by Test Type (2016-2030)
12.5.7.2. Market Revenue and Forecast, by Product (2016-2030)
12.5.7.3. Market Revenue and Forecast, by Application (2016-2030)
12.5.7.4. Market Revenue and Forecast, by Technology (2016-2030)
12.5.7.5. Market Revenue and Forecast, by End-use (2016-2030)
Chapter 13. Company Profiles
13.1. Abbott Laboratories
13.1.1. Company Overview
13.1.2. Application Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Qiagen N.V.
13.2.1. Company Overview
13.2.2. Application Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Becton, Dickinson and Company
13.3.1. Company Overview
13.3.2. Application Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Quest Diagnostics, Inc.
13.4.1. Company Overview
13.4.2. Application Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Hologic, Inc.
13.5.1. Company Overview
13.5.2. Application Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. F. Hoffmann-La Roche
13.6.1. Company Overview
13.6.2. Application Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Femasys, Inc.
13.7.1. Company Overview
13.7.2. Application Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Arbor Vita Corporation
13.8.1. Company Overview
13.8.2. Application Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. NURX, Inc.
13.9.1. Company Overview
13.9.2. Application Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Seegene, Inc.
13.10.1. Company Overview
13.10.2. Application Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
13.11. Thermo Fisher Scientific, Inc.
13.11.1. Company Overview
13.11.2. Application Offerings
13.11.3. Financial Performance
13.11.4. Recent Initiatives
13.12. bioMérieux SA
13.12.1. Company Overview
13.12.2. Application Offerings
13.12.3. Financial Performance
13.12.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms